Novel peanut skin extract as a vaccine adjuvant

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A23K 1/18 (2006.01) A61K 36/48 (2006.01) A61K 39/00 (2006.01) A61K 39/012 (2006.01) A61P 31/00 (2006.01) A61P 33/00 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2559272

The present invention relates to a novel adjuvant and/or immunomodulator isolated from peanut skin extract, which may be useful in the preparation of immunogenic compositions and vaccines. The present invention also provides for a method of stimulating acquisition of protective immunity by administering peanut skin extract prior to vaccination.

La présente invention concerne un adjuvant et/ou un modulateur de l'immunité isolé à partir d'extraits de peau d'arachide et convenant particulièrement à l'élaboration de compositions immunogènes et de vaccins. L'invention concerne également un procédé pour stimuler l'acquisition d'une immunité protectrice par administration d'extrait de peau d'arachide avant vaccination.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel peanut skin extract as a vaccine adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel peanut skin extract as a vaccine adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel peanut skin extract as a vaccine adjuvant will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1982904

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.